Secure Your Path to Global Reimbursement

Richard K. Baer, M.D., has served as Contract Medical Director for the Medicare Recovery Auditor for Region A in the northeast United States. Prior to that role, he was the Medical Director for the Medicare RAC Validation Contractor.

Dr Baer was formerly the Lead Medical Director for National Government Services (NGS), one of the nation’s largest Medicare administrative contractors (MAC). At NGS Dr. Baer had responsibilities for oversight of all medical policy activities for Medicare Parts A and B in all states in NGS’ jurisdictions.

Dr. Baer attended the University of Illinois, Abraham Lincoln School of Medicine in Chicago and completed residency training in psychiatry at the University of Illinois Hospitals. Dr. Baer practiced psychiatry for 12 years before joining Medicare in April 1994.

William Felix, M.D., M.Sc. AI-HC, is a healthcare executive and medical policy expert specializing in AI-driven healthcare solutions, payer strategy, and regulatory compliance. He served as Chief Medical Officer for Medicare DMEPOS and Medical Director of Pricing, Data Analysis, and Coding (PDAC) at Palmetto GBA, where he played a key role in policy development, HCPCS Level II coding, and utilization management.

A significant achievement during his tenure was facilitating CMS acceptance and reimbursement of 3D printing as a recognized method for custom fabrication in orthotics.

Dr. Felix also served as Vice President of Medical Policy for commercial and Medicare Advantage plans at Cohere Health, where he led medical policy initiatives and chaired the Utilization Management Committee.

Gianluca Furneri is a market access, pricing & health economics expert with 13 years experience in market access, both from a strategic consulting (Senior Consultant at SKP) and pharmaceutical industry (Health Economics Advisor at Pfizer) perspective. As a consultant, Gianluca supported clients to define market access strategies for the launch of pharmaceutical products and medical devices.

Gianluca's key strengths lie within pricing and health economic modelling and has supported clients in a number of projects focused on price-revenue optimization, health technology assessment, cost-effectiveness and budget impact analysis in the pharmaceutical, medical device and diagnostics fields.

Gianluca holds a Master Degree in Health Economics and Outcome Research, at the University of Milan.

Ernesto Gallone Arnaboldi is an expert in Italian market access (pricing and reimbursement) on a national and a regional level.

In his role as a market access and business development director in Takeda SpA, he has led national pricing and reimbursement negotiations, as well as regional access activities, overseeing a team of 16 people.

He has participated in European working groups for early market access evaluation and obtained a B.S. degree in Pharmaceutical Technologies at the University of Pavia.

Carlos Del Giudice Villar is an experienced market access specialist. In his role as a senior manager for public affairs in Novo Nordisk Pharma and a senior manager market access, tenders and pricing in Sanofi Pasteur MSD, Carlos has led market access and policy affairs teams, tenders and public procurements projects, as well as lobby activities with Spanish health authorities in the national and regional level.

Working for other leading healthcare companies, such as Baxter Healthcare and Aventis Pasteur MSD, he has gained substantial experience in developing market access plans, execution and follow up in the Spanish market.

Carlos has a Master’s Degree in Public Health Policies and Vaccines from Universidad Complutense de Madrid and B.S. degree in Pharmacy from Universidad de Alcalá de Henares.

Neil Grubert is a pharmaceutical market access specialist with 26 years of experience tracking the global prescription drug and self-medication markets. He has authored more than 150 reports on market access, covering 20 mature and emerging markets, multiple therapeutic areas, and numerous industry issues, including a recently published study on key market access trends in Europe.

He is currently working as an independent consultant and is developing a series of multi-client training programmes in market access.

Neil previously spearheaded the development of Decision Resources Group’s international market access business, most recently as Vice President of Global Market Access Insights. He has also done contract work on early-stage market access for GlaxoSmithKline.

Ferdinand Hundt is a licensed physician who worked as an anesthetist for the Klinikum der Johannes Gutenberg-Universität in Mainz from 1978 until 1988 when he joined the clinical research department of Janssen GmbH, Neuss.

Since 1991 Ferdinand Hundt has held various leading positions in clinical research with Sanofi Deutschland, most recently holding the position of Director Special Projects in Berlin. Since 2013, he is active as a consultant and senior advisor.

From 1999 to 2010 he was head of the Committee Clinical Research/Quality Assurance of the Verband Forschender Arzneimittelhersteller e.V. (VfA) (Association of Research-Based Pharmaceutical Companies). He is a member of the Clinical Quality Assurance Group Germany (CQAG) and a Fellow of the Faculty of Pharmaceutical Medicine (FFPM)/Royal Colleges of Physicians (UK), as well as a member of the Ethic Committee and the "Fortbildungsausschuss" (Committee of Continuous medical Education) of the "Landesärztekammer" Berlin (State Chamber of Physicians).

Professor Dr. Igl has served as a professor at the universities of Hamburg and Kiel in Germany. His subjects are German and European social law and public law.

Prof. Dr. Igl was also a consultant of statutory health and long-term care for the Europarat, the German Federal Health and Family ministries, the Health Committee of the German Federal Parliament (Deutscher Bundestag) and member of Enquete Commissions of the German Federal Parliament.

He is an expert in introducing medical products / devices into the German Statutory Health Insurance market.

Prof. Dr. Igl is actively lecturing, consulting and publishing in the above fields throughout Europe.

As an expert reimbursement consultant Amir works with organizations ranging from incubator start-ups to publicly traded companies, assisting them with the development of their reimbursement strategies in the US and Europe, their drug/device related value stories and economic models.

Prior to Mediclever, Amir worked for various software, telecom and medical device companies (Jungo Software Technologies, Iamba Networks and SuperDimensions), leading marketing, business development and reimbursement activities.

Amir runs the reimbursement course at the Graduate Program of the School of Business of the College of Management for MBA students with specialization in biomedical management.

Dr. Vincent Jaeger, a cardiovascular surgeon by training, is a consultant specializing in healthcare reimbursement of medical devices, procedures, drugs and diagnostics by Medicare, Medicaid and private payers.

Dr. Jaeger was National Head of the Department of Coverage and Reimbursement at Aetna for 7 years and held the same position at Health Net for 6 years. It was his responsibility to determine whether or not these companies should cover and reimburse new technologies as they entered the marketplace by critically analyzing the medical literature for adequate scientific evidence to prove their safety and effectiveness. He has personally written about 800 Medical Policies and supervised the development of another 800 policies establishing coverage positions.

Ross M. Miller, MD, MPH, FACPE is a seasoned healthcare executive and medical director with extensive experience in the industry, including managed care, pharmacy and therapeutics, medical devices, quality improvement, outcomes research, and population health.

Dr. Miller is also a Masters Degree-trained Health Outcomes Researcher with specialization in Health Services Management.

Dr. Miller is a well-published author in peer-reviewed health journals and a national speaker on various aspects of healthcare management with focus on U.S. payer perspectives.

Since 2003, Dr. Gerald Rogan offers coding, coverage, reimbursement, and compliance advice to health care stakeholders. He specializes in public payer programs, especially Medicare part B. He served as the carrier medical director for NHIC CA Part B Medicare from 1997-2003.

Dr. Rogan holds BA and MD degrees from the University of Michigan. He practiced emergency medicine and family practice for 23 years mostly in private practice in northern California providing a variety of inpatient, outpatient and home services.

He has consulted to the State of California, CMS, and state and federal law enforcement.